the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept bovine animals of a lower health status or subject to movement restrictions for animal health reasons or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment;

the animals come from an establishment free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding bovine animals, and one of the following conditions is fulfilled:

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the bovine population;

   or

2. (ii)

   the animals have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females taken at least 30 days after parturition;

   or

3. (iii)

   the animals are less than 12 months old;

   or

4. (iv)

   the animals are castrated;

the animals come from an establishment free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), and at least one of the following conditions is fulfilled:

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis);

   or

2. (ii)

   the animals have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) with one of the diagnostic methods provided for in Part 2 of Annex I, carried out, with negative results, during the last 30 days prior to departure;

   or

3. (iii)

   the animals are less than 6 weeks old;

the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

the animals come from an establishment in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to departure, and in case they come from an establishment in which surra (Trypanosoma evansi) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restrictions until:

1. (i)

   the infected animals have been removed from the establishment;

   and

2. (ii)

   the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;

except in the case of kept bovine animals referred to in Articles 11(4), 12(4) and Article 13, the animals fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;

the conditions set out in Articles 32 and 33 are fulfilled where applicable.

the animals come from an establishment free from enzootic bovine leukosis;

or

if the animals come from an establishment that is not free from enzootic bovine leukosis, then enzootic bovine leukosis has not been reported in that establishment during the last 24 months prior to departure, and

1. (i)

   if the animals are over 24 months of age, they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out with negative results

   • either on samples taken on two occasions at an interval of at least four months while kept in isolation from the other bovine animals of the establishment;

     or

   • on a sample taken during the last 30 days prior to their departure, and all bovine animals over 24 months kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of not less than four months during the last 12 months prior to the departure of the animals;

   or

2. (ii)

   in case the animals are less than 24 months of age, they were born to dams, which have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of not less than four months during the last 12 months prior to the departure of the animals.

if the animals come from an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis,

either

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;

   or

2. (ii)

   the animals have been subject to quarantine for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, carried out on a sample taken during the last 15 days prior to their departure;

if the animals come from an establishment not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, they have been kept in an approved quarantine establishment for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole BoHV-1, with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, carried out on a sample taken not less than 21 days after commencement of the quarantine.

if the animals come from an establishment free from bovine viral diarrhoea,

1. (i)

   the establishment is either situated in a Member State or zone thereof with the status free from bovine viral diarrhoea or has been subject to a testing regime as referred in point 1(c) (ii) or (iii) of Section 2 of Chapter 1 of Part VI of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the last four months prior to departure of the animals;

   or

2. (ii)

   the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to their departure;

if the animals come from an establishment not free from bovine viral diarrhoea, they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I, carried out with negative results, and

either

1. (i)

   the animals have been kept in an approved quarantine establishment for a period of at least 21 days prior to their departure and, in case of pregnant dams, they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, carried out, with negative results, on samples taken not less than 21 days after commencement of the quarantine;

   or

2. (ii)

   the animals have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, with positive results, carried out on samples taken either prior to departure or, in case of pregnant dams, before insemination preceding the current gestation.

the animals come from an establishment free from enzootic bovine leukosis;

or

if the animals come from an establishment that is not free from enzootic bovine leucosis, enzootic bovine leukosis has not been reported in that establishment during the last 24 months prior to departure of the animals, and

1. (i)

   in case the animals are over 24 months of age, they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results,

   either

   • on samples taken on two occasions at an interval of at least four months while kept in isolation from the other bovine animals of the establishment;

     or

   • on samples taken during the last 30 days prior to their departure, provided that all bovine animals over 24 months kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of at least four months during the last 12 months prior to the departure of the animals;

   or

2. (ii)

   in case the animals are less than 24 months of age, they were born to dams, which have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I, carried out, with negative results, on samples taken on two occasions at an interval of not less than four months during the last 12 months prior to the departure of the animals.

if the animals come from an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis,

either

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;

   or

2. (ii)

   the establishment is situated in a Member State or zone thereof with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;

   or

3. (iii)

   the animals have been subject to quarantine for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole BoHV-1 or, in case of animals vaccinated with a gE-deleted vaccine, antibodies against the BoHV-1 gE protein, with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, on a sample taken during the last 15 days prior to their departure;

   or

4. (iv)

   the animals are destined for an establishment which keeps bovine animals for meat production without contact to bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;

or

if the animals come from an establishment not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, they have been kept in an approved quarantine establishment for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole BoHV-1 with one of the diagnostic methods provided for in Part 5 of Annex I, with a negative result, on a sample taken not less than 21 days after commencement of the quarantine.

if the animals come from an establishment free from bovine viral diarrhoea,

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from bovine viral diarrhoea;

   or

2. (ii)

   the establishment is situated in a Member State or zone thereof with an approved eradication programme for bovine viral diarrhoea;

   or

3. (iii)

   the establishment has been subject to a testing regime as referred in point 1(c) (ii) or (iii) of Section 2 of Chapter 1 of Part VI of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the last four months prior to departure;

   or

4. (iv)

   the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to departure;

   or

5. (v)

   the animals are destined for an establishment which keeps bovine animals for meat production separate from bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;

if the animals come from an establishment not free from bovine viral diarrhoea, they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I, carried out, with negative results,

and

1. (i)

   the animals either have been kept in an approved quarantine establishment for a period of at least 21 days prior to their departure and, in case of pregnant dams, were subjected to a serological test for the detection of antibodies against the bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, carried out, with negative results, on samples taken not less than 21 days after commencement of the quarantine;

   or

2. (ii)

   the animals were subjected to a serological test for the detection of antibodies against the bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I, with positive results, carried out on samples taken either prior to departure or, in case of pregnant dams, before the insemination preceding the current gestation.

the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept ovine or caprine animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment;

except when they are moved in accordance with Article 16, they come from an establishment free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding ovine and caprine animals, and

either

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the ovine and caprine population;

   or

2. (ii)

   the animals have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females, taken at least 30 days after parturition;

   or

3. (iii)

   the animals are less than 6 months old;

   or

4. (iv)

   the animals are castrated.

the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus has not been reported in kept animals of listed species for that disease during the last 2 years prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

the animals come from an establishment in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to departure, and in case they come from an establishment in which surra (Trypanosoma evansi) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restrictions until:

1. (i)

   the infected animals have been removed from the establishment;

   and

2. (ii)

   the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;

except when the animals are moved in accordance with Article 17, they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;

the conditions set out in Articles 32 and 33 are fulfilled where applicable.

the animals come from an establishment in which ovine epididymitis (Brucella ovis) has not been reported during the last 12 months prior to departure;

the animals have been subjected to a serological test for ovine epididymitis (Brucella ovis), carried out, with negative results, on a sample taken during the last 30 days prior to departure.

the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept porcine animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment;

the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment in which infection with Aujeszky’s disease virus has not been reported during the last 30 days prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

the animals come from an establishment in which infection with Brucella abortus, B. melitensis and B. suis in porcine animals has not been reported during the last 42 days prior to departure, and in which during at least the last 12 months prior to departure

either

1. (i)

   biosecurity and risk mitigating measures, including housing conditions and feeding systems, have been applied as necessary to prevent transmission of infection with Brucella abortus, B. melitensis and B. suis from wild animals of listed species for that disease to porcine animals kept on the establishment, and only porcine animals from establishments applying equivalent biosecurity and risk mitigating measures have been introduced;

   or

2. (ii)

   surveillance for infection with Brucella abortus, B. melitensis and B. suis has been carried out on the porcine animals kept on the establishment in accordance with point 1 and point 2 of Annex III during at least the last 12 months prior to departure, and during this period

   • only porcine animals from establishments applying the measures provided for in point (i) or in this point have been introduced in the establishment referred to in point (a);

   • in case infection with Brucella abortus, B. melitensis and B. suis has been reported in porcine animals kept on the establishment, measures were taken in accordance with point 3 of Annex III.

if the animals come from an establishment free from infection with Aujeszky’s disease virus,

either

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infection with Aujeszky’s disease virus;

   or

2. (ii)

   the animals have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus with the diagnostic method provided for in Part 7 of Annex I, with a negative result, on a sample taken during the last 15 days prior to their departure. For porcine animals less than four months old born to dams vaccinated with a gE-deleted vaccine, the diagnostic method for the detection of antibodies against Aujeszky’s disease virus gE protein provided for in Part 7 of Annex I may be used. The number of porcine animals tested must allow at least for the detection of 10 % seroprevalence of the consignment with 95 % confidence;

if the animals come from an establishment not free from infection with Aujeszky’s disease virus, the following requirements are fulfilled:

1. (i)

   the animals have been kept in an approved quarantine establishment for a period of at least 30 days;

   and

2. (ii)

   the animals have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus with the diagnostic method provided for in Part 7 of Annex I, with a negative result, carried out on samples taken on two occasions at an interval of not less than 30 days, the last sample taken during the last 15 days prior to departure.

if the animals come from an establishment free from infection with Aujeszky’s disease virus,

either

1. (i)

   the establishment is situated in a Member State or zone thereof with the status free from infection with Aujeszky’s disease virus;

   or

2. (ii)

   the establishment is situated in a Member State or zone thereof with an approved eradication programme for infection with Aujeszky’s disease virus;

   or

3. (iii)

   the animals have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus or antibodies against Aujeszky’s disease virus-gE protein, where applicable, with one of the diagnostic methods provided for in Part 7 of Annex I, with a negative result, on a sample taken during the last 15 days prior to their departure. The number of porcine animals tested must allow at least for the detection of 10 % seroprevalence of the consignment with 95 % confidence;

if the animals come from an establishment not free from infection with Aujeszky’s disease virus the following requirements are fulfilled:

1. (i)

   they have been kept in an approved quarantine establishment for a period of at least 30 days;

   and

2. (ii)

   they have been subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus or antibodies against Aujeszky’s disease virus gE protein, where applicable, with one of the diagnostic methods provided for in Part 7 of Annex I, with a negative result, carried out on samples taken on two occasions at an interval of not less than 30 days, the last sample taken during the last 15 days prior to departure.

in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

in which anthrax in ungulates has not been reported during the last 15 days prior to departure.

the animals come from an establishment in which infection with Aujeszky’s disease virus has not been reported during the last 30 days prior to departure;

the animals are transported directly to the slaughterhouse in the Member State of destination without undergoing any assembly operations in that Member State or zone thereof, or any Member State or zone thereof of passage with the status free from infection with Aujeszky’s disease virus.

the animals come from an establishment in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to departure, or in case they come from an establishment in which surra (Trypanosoma evansi) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:

1. (i)

   the infected animals have been removed from the establishment,

   and

2. (ii)

   the remaining animals in the establishment have been subjected to a test for surra (Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the last infected animal has been removed from the establishment;

the animals come from an establishment in which dourine has not been reported during the last 6 months prior to departure, or in case they come from an establishment in which dourine has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:

1. (i)

   the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated;

   and

2. (ii)

   the remaining equine animals in the establishment, with the exception of the castrated male equine animals referred to in point (i), have been subjected to a test for dourine with the diagnostic method provided for in Part 8 of Annex I, carried out, with negative results, on samples taken at least 6 months after the measures described in point (i) have been completed;

the animals come from an establishment in which equine infectious anaemia has not been reported during the last 90 days prior to departure, or in case they come from an establishment in which equine infectious anaemia has been reported during the last 12 months prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:

1. (i)

   the infected animals have been killed and destroyed or slaughtered and the establishment was cleaned and disinfected;

   and

2. (ii)

   the remaining animals in the establishment have been subjected to a test for equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I, carried out, with negative results, on samples taken on two occasions with a minimum interval of 3 months after the measures described in point (i) have been completed;

the animals come from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the last 6 months prior to departure, or in case they come from an establishment situated in a Member State or zone thereof in which Venezuelan equine encephalomyelitis has been reported during the last 2 years, they comply with the conditions in point (i) and the conditions in either point (ii) or point (iii):

1. (i)

   during the period of at least 21 days prior to departure they have remained clinically healthy and any animal referred to in point (ii) or point (iii) which showed a rise in body temperature above physiological range, taken daily, have been subjected to a diagnostic test for Venezuelan equine encephalomyelitis with the diagnostic method provided for in point (a) of Part 10(1) of Annex I, with negative results;

   and

2. (ii)

   the animals were kept in quarantine for a period of at least 21 days protected from attacks by insect vector, and

   either

   • have been vaccinated against Venezuelan equine encephalomyelitis with a complete primary course and revaccinated according to manufacturer’s recommendations not less than 60 days and not more than 12 months prior to the date of dispatch;

     or

   • have been subjected to a test for Venezuelan equine encephalomyelitis with the diagnostic method provided for in point (b) of Part 10(1) of Annex I, carried out, with negative results, on a sample taken not less than 14 days after the date of entry into quarantine;

3. (iii)

   the animals have been subjected to

   • a test for Venezuelan equine encephalomyelitis with the diagnostic method provided for in point (b) of Part 10(1) of Annex I, without an increase in antibody titre, carried out on paired samples taken on two occasions with an interval of 21 days, the second of which was taken during a period of 10 days prior to the date of departure;

     and

   • a test for the detection of Venezuelan equine encephalomyelitis virus genome with the diagnostic method provided for in Part 10(2) of Annex I, with negative result, carried out on a sample taken within 48 hours prior to departure, and the animals have been protected from attacks by insect vectors after sampling until departure;

the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

the animals have not been in contact with kept animals of listed species for the diseases referred to in points (a) to (f) which did not comply with the requirements in points (a) to (e) during the last 30 days prior to departure, and with the requirement in point (f) during the last 15 days prior to departure.

the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept camelid animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment;

the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment in which infection with Brucella abortus, B. melitensis and B. suis in camelid animals has not been reported during the last 42 days prior to departure, and they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I, carried out, with negative results, on a sample taken during the last 30 days prior to departure, and in the case of post-parturient females taken at least 30 days after parturition;

the animals come from an establishment in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the camelid animals kept on the establishment in accordance with point (1) and point (2) of Part 2 of Annex II during at least the last 12 months prior to departure, and during this period

1. (i)

   only camelid animals from establishments applying the measures provided for in this point have been introduced in the establishment referred to in point (a);

2. (ii)

   in case infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in camelid animals kept on the establishment, measures were taken in accordance with point 3 of Part 2 of Annex II.

in case the animals are moved to a Member State or zone thereof with disease-free status or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals, they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in camelid animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus has not been reported in any establishment during the last 2 years prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

the animals come from an establishment in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to departure, and in case they come from an establishment on which surra (Trypanosoma evansi) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:

1. (i)

   the infected animals have been removed from the establishment;

   and

2. (ii)

   the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;

except when the animals are moved in accordance with Article 24, they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;

the conditions set out in Articles 32 and 33 are fulfilled where applicable.

the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept cervid animals of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment;

the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment in which infection with Brucella abortus, B. melitensis and B. suis in cervid animals has not been reported during the last 42 days prior to departure;

the animals come from an establishment in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the cervid animals kept on the establishment in accordance with point (1) and point (2) of Part 3 of Annex II during at least the last 12 months prior to departure, and during this period

1. (i)

   only cervid animals from establishments applying the measures provided for in this point have been introduced in the establishment referred to in point (a);

2. (ii)

   in case infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in cervid animals kept on the establishment, measures were taken in accordance with point (3) of Part 3 of Annex II;

in case the animals are moved to a Member State or zone thereof with disease-free status or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals, they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in cervid animals has not been reported during the last 30 days prior to departure;

the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus has not been reported in any establishment during the last 2 years prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

the animals come from an establishment in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to departure, and in case they come from an establishment on which surra (Trypanosoma evansi) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:

1. (i)

   the infected animals have been removed from the establishment;

   and

2. (ii)

   the remaining animals on the establishment have been subjected to a test for surra (Trypanosoma evansi) with one of the diagnostic methods provided for in Part 3 of Annex I, carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;

except when they are moved in accordance with Article 27, they comply with at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;

the conditions set out in Articles 32 and 33 are fulfilled where applicable.

the animals have been continuously resident in the establishment for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with other kept ungulates of a lower health status or subject to movement restrictions for animal health reasons, or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in point (a), and introduced into the establishment where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment;

in the case of other kept ungulates of listed species for infection with rabies virus, the animals come from an establishment in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to departure;

in the case of other kept ungulates of listed species for infection with Brucella abortus, B. melitensis and B. suis, they come from an establishment in which infection with Brucella abortus, B. melitensis and B. suis in other kept ungulates of listed species for this disease has not been reported during the last 42 days prior to departure;

in the case of other kept ungulates of listed species for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), they come from an establishment in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in kept animals of listed species for this disease has not been reported during the last 42 days prior to departure;

in the case of other kept ungulates of listed species for infection with epizootic haemorrhagic disease virus, the animals come from an establishment situated in an area of at least 150 km radius around that establishment in which infection with epizootic haemorrhagic disease virus has not been reported in any establishment during the last 2 years prior to departure;

the animals come from an establishment in which anthrax in ungulates has not been reported during the last 15 days prior to departure;

in the case of other kept ungulates of listed species for surra (Trypanosoma evansi), they come from an establishment in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to departure, and in case they come from an establishment on which surra (Trypanosoma evansi) has been reported during the last 2 years prior to departure, following the last outbreak the affected establishment has remained under movement restriction until:

1. (i)

   the infected animals have been removed from the establishment;

   and

2. (ii)

   the remaining animals on the establishment have been tested with one of the diagnostic methods provided for in Part 3 of Annex I for surra (Trypanosoma evansi), carried out, with negative results, on samples taken at least 6 months after the infected animals have been removed from the establishment;

in the case of other kept ungulates of listed species for infection with Bluetongue virus (serotype 1-24), they fulfil at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689. This point shall not apply to other kept ungulates referred to in Article 30.

the conditions set out in Articles 32 and 33 are fulfilled where applicable.

the transport takes place in a Member State or zone thereof with the status free from infection with Bluetongue virus (serotypes 1-24);

the animals are protected from attacks by vectors;

and

1. (i)

   the planned journey does not include the unloading of the animals for a period longer than one day;

   or

2. (ii)

   the animals are unloaded in a vector protected establishment;

   or

3. (iii)

   the animals are unloaded in a Member State or a zone thereof during the vector-free period;

the animals

1. (i)

   have been vaccinated against all the serotypes of Bluetongue virus (serotypes 1-24) reported during the last two years in the Member State or zone thereof of passage and they are still within the immunity period of time guaranteed in the specifications of the vaccine;

   or

2. (ii)

   were subjected with positive results to a serological test able to detect specific antibodies against all serotypes of Bluetongue virus (serotypes 1-24) reported in the Member State or zone thereof of passage during the last two years prior to departure;

the animals are intended for slaughter.

the animals fulfil the specific animal health requirements defined by the competent authority of destination to ensure the animals, prior to departure, have sufficient immunological protection as regards all serotypes of Bluetongue virus (serotypes 1-24) reported in the Member State or zone thereof of passage during the last two years prior to departure;

or

the animals fulfil the requirements laid down in point (a) of this paragraph or in point (c) of paragraph 1 in order to ensure they are protected against the serotypes of Bluetongue virus reported in the Member State or zone thereof of passage during the last two years prior to departure and not reported in the Member State or zone of destination during the same period.

the animals fulfil at least one of one of the requirements set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;

or

the means of transport where the animals are loaded have been protected from attacks by vectors during transport;

and

1. (i)

   the planned journey does not include the unloading of the animals for a period longer than one day;

   or

2. (ii)

   the animals are unloaded in a vector protected establishment or during the vector-free period.